Abiopharma

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Agilysys to Participate in the William Blair 46th Annual Growth Stock Conference

DHI Group to Present at the Noble Capital Markets Emerging Growth Virtual Equity Conference on June 4, 2026

Heidmar Maritime Holdings Corp. Announces Transition in Chief Financial Officer Role

HPE Reports Fiscal 2026 Second Quarter Results

Ampco-Pittsburgh Corporation to Present at the East Coast IDEAS Investor Conference on June 10, 2026, in New York

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

Fluor Joint Venture Receives Limited Notice to Proceed for Proposed Phase 2 Expansion of LNG Canada Facility

Thornburg Income Builder Opportunities Trust Announces Distribution

Definium Therapeutics Announces New Employee Inducement Grants